# Simmons First National Corp: overview

SFNC · Nasdaq · CIK 90498 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sfnc.md) · [Financials](/companies/sfnc/financials.md) · [Filings](/companies/sfnc/filings.md) · [Insiders](/companies/sfnc/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.20](/filings/0001628280-25-050112.md) | not reported | [0.26](/filings/0001628280-26-031205.md) | [0.43](/filings/0001628280-26-053273.md) | [(4.00)](/filings/0001628280-25-050112.md) | not reported | [0.47](/filings/0001628280-26-031205.md) | [0.46](/filings/0001628280-26-053273.md) |
| Free cash flow | $m | [188 d](/filings/0001628280-25-050112.md) | [72.3 d](/filings/0001628280-26-011618.md) | [22.6](/filings/0001628280-26-031205.md) | [66.3 d](/filings/0001628280-26-053273.md) | [217 d](/filings/0001628280-25-050112.md) | [106 d](/filings/0001628280-26-011618.md) | [34.0](/filings/0001628280-26-031205.md) | [126 d](/filings/0001628280-26-053273.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.46](/filings/0001628280-24-007263.md) | [2.06](/filings/0001628280-25-008639.md) | [1.38](/filings/0001628280-26-011618.md) | [1.21](/filings/0001628280-26-011618.md) | [(2.95)](/filings/0001628280-26-011618.md) |
| Free cash flow | $m | [230](/filings/0001628280-24-007263.md) | [287](/filings/0001628280-25-008639.md) | [508](/filings/0001628280-26-011618.md) | [380](/filings/0001628280-26-011618.md) | [411](/filings/0001628280-26-011618.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sfnc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $471.3m | 20,808,072 |  | Added +85,540 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $199.6m | 8,812,134 |  | Added +5,238 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $186.0m | 8,137,938 |  | Added +500,888 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $149.8m | 6,613,638 |  | Added +67,225 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $149.3m | 6,591,542 |  | Added +245,024 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $138.4m | 6,110,810 |  | Reduced −134,866 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $98.8m | 4,362,714 |  | Reduced −20,254 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $88.5m | 3,906,857 |  | Added +246,608 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $76.4m | 3,371,893 |  | Added +821,778 |
| [WESTWOOD HOLDINGS GROUP INC](/funds/1165002.md) | 2026-06-30 | $69.8m | 3,082,648 |  | Reduced −426,183 |

## Recent filings

[All 2,606 filings](/companies/sfnc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 20:30 ET | [8-K](/filings/0001193125-26-422936.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-422936 |
| 2026-09-03 | 20:31 ET | [8-K](/filings/0001193125-26-381967.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure | 0001193125-26-381967 |
| 2026-08-05 | 20:01 ET | [10-Q](/filings/0001628280-26-053273.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053273 |
| 2026-07-16 | 20:30 ET | [8-K](/filings/0001193125-26-306164.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-306164 |
| 2026-05-13 | 21:29 ET | [8-K](/filings/0001193125-26-221998.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-221998 |
| 2026-05-06 | 19:55 ET | [10-Q](/filings/0001628280-26-031205.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031205 |
| 2026-04-16 | 20:31 ET | [8-K](/filings/0001193125-26-159123.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-159123 |
| 2026-04-08 | 12:30 ET | [DEF 14A](/filings/0001193125-26-146412.md) | Proxy statement, period 2026-05-13 | 0001193125-26-146412 |
| 2026-03-03 | 21:34 ET | [8-K](/filings/0001193125-26-088388.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-088388 |
| 2026-02-25 | 21:04 ET | [10-K](/filings/0001628280-26-011618.md) | Annual report, period 2025-12-31 | 0001628280-26-011618 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-011618.md), filed Feb 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 90498
- Tickers: SFNC
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: AR
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.